Skip to Main Content

Paper Details

CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity.
Epilepsia
14
2021
CSNK2B, CSNK2B variants, NDD, developmental delay, disease, epilepsy, epilepticus, generalized epilepsy, intellectual disability, neurodevelopmental disability, patients, seizures
Author NameAffiliation
Erin L HeinzenInstitute for Genomic Medicine, Columbia University Irving Medical Center
Erin L HeinzenEshelman School of Pharmacy, University of North Carolina at Chapel Hill
Weimin BiBaylor College of Medicine
Neil A HanchardBaylor College of Medicine
Eric W KleeCenter for Individualized Medicine, Mayo Clinic
Eric W KleeMayo Clinic
Marissa S EllingsonMayo Clinic
Matthew J FerberClinical Genome Sequencing Laboratory, Mayo Clinic
Alejandra VasquezBoston Children's Hospital
Alejandra VasquezMayo Clinic
David B GoldsteinInstitute for Genomic Medicine, Columbia University Irving Medical Center
David B GoldsteinInstitute for Genomic Medicine, Columbia University Irving Medical Center
Tristan T SandsInstitute for Genomic Medicine, Columbia University Irving Medical Center
Tristan T SandsThe Neurological Institute of New York, Columbia University Irving Medical Center
  • 1 - 14

Datasets

Release 1.2